1. Home
  2. TGTX vs SIRI Comparison

TGTX vs SIRI Comparison

Compare TGTX & SIRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TG Therapeutics Inc.

TGTX

TG Therapeutics Inc.

HOLD

Current Price

$55.33

Market Cap

8.5B

Sector

Health Care

ML Signal

HOLD

Logo Sirius XM Holdings Inc.

SIRI

Sirius XM Holdings Inc.

HOLD

Current Price

$30.96

Market Cap

9.3B

ML Signal

HOLD

Company Overview

Basic Information
Metric
TGTX
SIRI
Founded
1993
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Broadcasting
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
8.5B
9.3B
IPO Year
2008
1996

Fundamental Metrics

Financial Performance
Metric
TGTX
SIRI
Price
$55.33
$30.96
Analyst Decision
Strong Buy
Buy
Analyst Count
5
8
Target Price
$49.80
$28.86
AVG Volume (30 Days)
2.5M
4.3M
Earning Date
05-04-2026
04-30-2026
Dividend Yield
N/A
4.03%
EPS Growth
1746.67
136.32
EPS
0.12
0.72
Revenue
$2,785,000.00
$5,425,129,000.00
Revenue This Year
$49.08
$1.81
Revenue Next Year
$26.69
$0.67
P/E Ratio
$459.33
$42.01
Revenue Growth
N/A
8.13
52 Week Low
$25.37
$19.77
52 Week High
$59.30
$31.42

Technical Indicators

Market Signals
Indicator
TGTX
SIRI
Relative Strength Index (RSI) 60.43 68.09
Support Level $28.57 $20.30
Resistance Level $57.38 $31.42
Average True Range (ATR) 2.40 0.83
MACD -0.54 0.08
Stochastic Oscillator 51.47 87.34

Price Performance

Historical Comparison
TGTX
SIRI

About TGTX TG Therapeutics Inc.

TG Therapeutics Inc is a fully integrated, commercial-stage biotechnology company focused on acquiring, developing, and commercializing novel treatments for B-cell diseases. In addition to a research pipeline, TG Therapeutics has received approval from the U.S. Food and Drug Administration (FDA) for BRIUMVI (ublituximab-xiiy) to treat adult patients with relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, as well as approval from several regulatory agencies outside of the U.S. for BRIUMVI to treat adult patients with RMS who have active disease defined by clinical or imaging features.

About SIRI Sirius XM Holdings Inc.

Sirius XM operates almost exclusively in the US through its SiriusXM and Pandora audio services. SiriusXM is primarily a satellite radio service that offers nationwide coverage and mostly ad-free listening, with proprietary channels and exclusive content. It makes agreements with automakers to install its radios in vehicles and give trial services to vehicle buyers, which have traditionally fed its subscriber base. The company provides the service via a fleet of geostationary satellites it owns and operates and now offers a streaming SiriusXM option. Pandora, which accounts for a much smaller portion of revenue and profit, offers a subscription and ad-supported streaming music service that competes with industry giants such as Spotify, Apple Music, and YouTube Music.

Share on Social Networks: